Caleb Cornaby, Ph.D., F(ACHI)
Dr. Caleb Cornaby obtained his Ph.D. from the department of Microbiology and Molecular Biology at Brigham Young University, Provo, Utah. He received advanced training in immunology and research methods at the University of Florida College of Medicine studying therapeutics and disease development markers in animal models of Systemic Lupus Erythematosus with Dr. Lorance Morel, Ph.D. Under the mentorship of Dr. John Schmitz, Ph.D. and Dr. Eric Weimer, Ph.D., he received training in medical immunology, clinical flow cytometry and histocompatibility. He is a past fellow of the American Society of Microbiology CPEP clinical immunology fellowship program and previous director in training at the University of North Carolina School of Medicine, Chapel Hill.
Dr. Cornaby is actively involved in several professional societies including the American Society for Clinical Pathologists (ASCP), American Society of Microbiology (ASM), Association of Medical Laboratory Immunologists (AMLI) and American Society for Histocompatibility and Immunogenetics (ASHI) among others. As a result, he enjoys being involved in several committees including the abstract review and nomination committees. He also has the opportunity to review manuscripts for a variety of scientific peer reviewed journals including the Journal of Immunological Methods, Frontiers in Immunology, JAMA Pediatrics, and Human Immunology.
He currently serves as the assistant director of the Histocompatibility and Immunogenetics laboratory as well as the assistant director of the Diagnostic Immunology and Flow Cytometry laboratory in the Department of Pathology and Laboratory Medicine at Children’s Hospital Los Angeles. He is an Assistant Professor of Clinical Pathology at the Keck School of Medicine of USC. His primary areas of research interest include development of new methods to improving clinical laboratory practices, clinical pathology diagnostic test development for inborn errors of immunity, as well as new methods for the assessment and evaluation of Human Leukocyte Antigen (HLA) antibody testing.